Elodie Segura awarded a grant from Amgen

Elodie Segura has been awarded a grant from the 'Fonds Amgen France pour la Science et l'Humain' to continue understanding the role of Aryl Hydrocarbon Receptor in anti-tumoral responses (press release here). See the video presentation of the project here (in French).